Dr. Ashraf Reyad is a multi-organ transplant surgeon, dually board certified by The American Board of Surgery and The Intercollegiate Royal College of Surgeons.He graduated as a top 5th percentile graduate of The Royal College of Surgeons in Ireland. In 2011, he completed his preliminary surgical internship at The John Hopkins Hospital. He was awarded the esteemed Gersh Effron Resident of the Year Award for three consecutive years during his surgical residency training at Sinai Hospital of Baltimore, which he completed in 2015. Dr. Reyad completed his abdominal transplant fellowship training at The John Hopkins Hospital in Baltimore, Maryland.As a surgeon he was part of the first clinical trial successfully transplanting Hepatitis C positive kidneys into Hepatitis C negative patients known as the EXPANDER -1 trial. Dr. Reyad was also part of the surgical team to perform the first HIV positive to HIV positive organs procurements and kidney transplants (the HOPE Act) in the U.S. and the first HIV positive to HIV positive liver transplant in the world. His expertise includes managing highly immuno-sensitized patients, ABO blood group incompatible transplants, hyper-coagulable patients, as well as the care of patients with multiple prior organ transplantations.Currently, he is the surgical director at Medical City Fort Worth transplant Institute, which is ranked amongst the best in the country for shortest transplant wait times and one year outcomes.Dr. Reyad also performs transplant related surgeries hand assisted laparoscopies, donor nephrectomies, simultaneous pancreas and kidney transplants, kidney transplants, pancreas transplants, access surgery and robotic assisted surgeries.